Results 21 to 30 of about 880,080 (267)

Vascular nursing and vascular surgery

, 2020
Background: Patients requiring vascular surgery have turned in older subjects with several comorbidities with frailty problems and increased vulnerability.
Licastro N., Bracale U. M., Ielapi N., Catana M., Serra R.   +4 more
core   +1 more source

Financial Implications of COVID-19 on a Tertiary Academic Vascular Surgery Practice

, 2021
The COVID-19 pandemic has had an unprecedented impact on the healthcare system in the United States. The redistribution of resources and suspension of elective procedures and other services has placed a financial stress across all service lines.
Fang, Zachary B., Schanzer, Andres, Arous, Edward J., Simons, Jessica P., Steppacher, Robert, Jones, Douglas W., Judelson, Dejah R., Aiello, Francesco A.   +7 more
core   +1 more source

Editor's choice : European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on antithrombotic therapy for vascular diseases

, 2023
The European Society for Vascular Surgery (ESVS) has developed a series of clinical practice guidelines for clinicians caring for patients with vascular diseases. This is the first guideline specifically examining antithrombotic therapy.
ESVS Guideline Committee, [missing], Aboyans, V., Jilma, Bernd, Twine, C. P., Behrendt, C. A., Jilma, B., Nordanstig, Joakim,, Bellmunt-Montoya, S., Behrendt, Christian-Alexander, Nordanstig, Joakim, Twine, Christopher P., Reekers, Jim A., Baumgartner, Iris, Zlatanovic, Petar, Zlatanovic, P., Saratzis, Athanasios, Reekers, J. A., Wanhainen, Anders,, Saratzis, A., Kakkos, Stavros K., Vermassen, Frank, Kakkos, S. K., Baumgartner, I., ESVS Guidelines Committee, Aboyans, Victor, Bellmunt-Montoya, Sergi   +25 more
core   +1 more source

Education in vascular surgery: Critical issues around the globe—training and qualification in vascular surgery in Europe

, 2008
In 1958, the Union Européene des Médecins Spécialistes (UEMS), or European Union (EU) of Medical Specialists the European Union, was founded by the professional organizations of medical specialists in Europe.
Benedetti-Valentini, Fabrizio, Pandey, Vikas, Liapis, Christos D., Cairols, Marc, Bergqvist, David,, Bergqvist, David, Wolfe, John, van Bockel, J. Hajo   +7 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu, Kaitlin LaGasse, Cory D. Saucier, Kimberly Raymond, Miranda Lauher‐Charest, Lauren Crowder, Beilei Cai, Mary Lisha Paul, Denise Adams   +8 more
wiley   +1 more source

Infection Control Practices for Vascular Access Management in Hemodialysis: Results From a Nationwide Survey of Japanese National University Hospitals

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Bloodstream infections due to repeated vascular access (VA) puncture and circuit connections remain major concerns in hemodialysis. Therefore, we examined current practices for glove, disinfectant, and personal protective equipment (PPE) use according to VA type in national university hospitals in Japan.
Aiko Yamada, Makoto Harada, Tadahiko Kikugawa, Takeshi Nakata, Koji Hashimoto, Tsuneo Konta, Yuji Kamijo   +6 more
wiley   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura, Akira Miyamoto   +9 more
wiley   +1 more source

Insurance Claims after Vascular Surgery in Sweden

, 2011
ObjectivesThe study aimed to estimate the incidence and causes of insurance claims (IC) after vascular surgery (VS) reported to the Swedish Medical Injury Insurance (SMII); and to validate the registration of complications in the National Vascular ...
Ahlberg, J., M. Björck, Björck, M., Rudström, H., J. Ahlberg, Bergqvist, David,, Björck, Martin,, H. Rudström, Rudström, Håkan,, D. Bergqvist, Bergqvist, D.   +10 more
core   +1 more source

Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory ...
Kunihiro Ishioka, Takayasu Ohtake, Kei Ohmori, Chika Shibuya, Tomoki Tsukahara, Mizuki Yamano, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Yusuke Tsukamoto, Hidekazu Moriya, Sumi Hidaka, Shuzo Kobayashi   +12 more
wiley   +1 more source